The Microbiome and Sustainable Healthcare.

作者: Rodney Dietert , Janice Dietert

DOI: 10.3390/HEALTHCARE3010100

关键词: Gut floraEnvironmental healthAntibiotic useHealth riskAntibiotic resistancePersonalized medicineMicrobiomeBiotechnologyBiologyLife course approachHealth care

摘要: Increasing prevalences, morbidity, premature mortality and medical needs associated with non-communicable diseases conditions (NCDs) have reached epidemic proportions placed a major drain on healthcare systems global economies. Added to this are the challenges presented by overuse of antibiotics increased antibiotic resistance. Solutions needed that can address NCDs increasing resistance, maximize preventative measures, balance available services economic realities. Microbiome management including microbiota seeding, feeding, rebiosis appears likely be core component path toward sustainable healthcare. Recent findings indicate that: (1) humans mostly microbial (in terms numbers cells genes); (2) immune dysfunction misregulated inflammation pivotal in majority NCDs; (3) microbiome status affects early education risk NCDs, (4) certain infections. Management reduce later-life health and/or treat emerging spare use recurrent infections may provide more effective strategy across life course particularly when personalized medicine approach is considered. This review will examine potential for contribute

参考文章(204)
A. Nitsch-Osuch, D. Kurpas, E. Kuchar, K. Życińska, T. Zielonka, K. Wardyn, Antibiotic consumption pattern in the neonatal special care unit before and after implementation of the hospital's antibiotic policy. Advances in Experimental Medicine and Biology. ,vol. 835, pp. 45- 51 ,(2014) , 10.1007/5584_2014_32
Nadia Gaci, Guillaume Borrel, William Tottey, Paul William O’Toole, Jean-François Brugère, Archaea and the human gut: New beginning of an old story World Journal of Gastroenterology. ,vol. 20, pp. 16062- 16078 ,(2014) , 10.3748/WJG.V20.I43.16062
Nobuyuki Sudo, Microbiome, HPA Axis and Production of Endocrine Hormones in the Gut Advances in Experimental Medicine and Biology. ,vol. 817, pp. 177- 194 ,(2014) , 10.1007/978-1-4939-0897-4_8
Kevin Brown, The history of penicillin from discovery to the drive to production. Pharmaceutical historian. ,vol. 34, pp. 37- 43 ,(2004)
Niklas Kahr, Vibeke Naeser, Lone Graff Stensballe, Kirsten Ohm Kyvik, Axel Skytthe, Vibeke Backer, Klaus Bønnelykke, Simon Francis Thomsen, Gene-environment interaction in atopic diseases: a population-based twin study of early-life exposures The Clinical Respiratory Journal. ,vol. 9, pp. 79- 86 ,(2015) , 10.1111/CRJ.12110
Kun Lu, Ridwan Mahbub, Peter Hans Cable, Hongyu Ru, Nicola MA Parry, Wanda M Bodnar, John S Wishnok, Miroslav Styblo, James A Swenberg, James G Fox, Steven R Tannenbaum, None, Gut Microbiome Phenotypes Driven by Host Genetics Affect Arsenic Metabolism Chemical Research in Toxicology. ,vol. 27, pp. 172- 174 ,(2014) , 10.1021/TX400454Z
Michael de Vrese, J. Schrezenmeir, Probiotics, Prebiotics, and Synbiotics Advances in Biochemical Engineering \/ Biotechnology. ,vol. 111, pp. 1- 66 ,(2008) , 10.1007/10_2008_097
S. D. Udayappan, A. V. Hartstra, G. M. Dallinga-Thie, M. Nieuwdorp, Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus Clinical and Experimental Immunology. ,vol. 177, pp. 24- 29 ,(2014) , 10.1111/CEI.12293